← Open Payments lookup

MELISSA RIEBEN: Open Payments

NPI 1720485162 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$744 in 36 payments from 18 companies in 2025. Trend: 2023 $2,072 · 2024 $2,233 · 2025 $744

Food & beverage: $744
CompanyPaymentsAmount
Novo Nordisk Inc10$212
Lilly USA, LLC4$84
AstraZeneca Pharmaceuticals LP3$59
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$53
Lundbeck LLC2$46
ABBVIE INC.2$46
Otsuka America Pharmaceutical, Inc.1$30
Merck Sharp & Dohme LLC1$28
Boehringer Ingelheim Pharmaceuticals, Inc.1$25
Abbott Laboratories1$23

Products named: Wegovy, MOUNJARO, Ozempic, XIFAXAN, Rybelsus, VYEPTI, BREZTRI, REXULTI.

Industry payments across MD — which companies pay providers there.